Search the site

Colostrum, the missing link for healthy growth

Valerie Verhasselt MD, PhD Head, Immunology and Breastfeeding 0402997617 Valerie.verhasselt@thekids.org.au Head, Immunology and Breastfeeding @

Combatting the Normalisation of Sports Gambling and Aggressive Marketing Tactics that Compromise the Mental Health and Wellbeing of Australian Youth

Sports gambling has become increasingly normalised among young people, with the proliferation of sponsorship deals and a 300% rise in the number of gambling advertisements in the past 7 years.

Community immunity: Developing a sensitive and specific SARS-CoV-2 antibody test

Peter Richmond MBBS MRCP(UK) FRACP Head, Vaccine Trials Group Head, Vaccine Trials Group Professor Peter Richmond is Head of the Vaccine Trials Group

Complex Experiences of Gender Affirmation

This project explores the mental health and support needs of Australians with complex experiences of gender-affirmation.

Compound Repurposing Into Novel Therapeutics In COVID-19 At risk Lungs (CRITICAL Study)

Anthony Christopher David Ingrid Shannon Thomas Kicic Blyth Martino Laing Simpson Iosifidis BSc (Hons) PhD MBBS (Hons) DCH FRACP FRCPA PhD BSc PhD

CONNECT-CP (A Clinical Research Program to Improve Connection, Access and Translation of Evidence in Cerebral Palsy)

CONNECT-CP aims to diagnose cerebral palsy (CP) earlier and ensure all children in Western Australia (WA) have access to early assessment and support.

Core Competencies and Reporting Guidelines for Co-research with Adolescents (The C3 Study)

The C3 Study is an exploration into best practice around co-research with youth consumers being led by the Adolescent Health and Wellbeing Team at The Kids Research Institute Australia, who are based in Adelaide.

Frequently Asked Questions

Explore some of the frequently asked questions that The C3 Study receives.

COVALIA (COVid vaccine trial for austrALIA): A phase I, double-blind, dose-ranging, randomised, placebo-controlled trial to study the safety and immunogenicity of a DNA-based vaccine against COVID-19 (COVIGEN) in healthy participants aged 18 to 75 years o

Peter Richmond MBBS MRCP(UK) FRACP Head, Vaccine Trials Group Head, Vaccine Trials Group Professor Peter Richmond is Head of the Vaccine Trials Group

Defining the cellular immune response to vaccines for enhanced protection from invasive pneumococcal disease

Peter Lea-Ann Ruth Richmond Kirkham Thornton MBBS MRCP(UK) FRACP PhD PhD Head, Vaccine Trials Group Co-Head, Bacterial Respiratory Infectious Disease